Qiu Rao

2.9k total citations
109 papers, 1.5k citations indexed

About

Qiu Rao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Qiu Rao has authored 109 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 63 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Qiu Rao's work include Renal cell carcinoma treatment (46 papers), Renal and related cancers (40 papers) and Sarcoma Diagnosis and Treatment (15 papers). Qiu Rao is often cited by papers focused on Renal cell carcinoma treatment (46 papers), Renal and related cancers (40 papers) and Sarcoma Diagnosis and Treatment (15 papers). Qiu Rao collaborates with scholars based in China, United States and Spain. Qiu Rao's co-authors include Xiaojun Zhou, Qiuyuan Xia, Heng‐hui Ma, Shanshan Shi, Qun-Li Shi, Zhenfeng Lu, Liang Cheng, Bo Yu, Qin Shen and Rusong Zhang and has published in prestigious journals such as PLoS ONE, Oncogene and Annals of Oncology.

In The Last Decade

Qiu Rao

101 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiu Rao China 23 869 857 401 378 288 109 1.5k
Serena Pedron Italy 21 805 0.9× 604 0.7× 227 0.6× 354 0.9× 230 0.8× 48 1.6k
Mariza de Peralta‐Venturina United States 13 717 0.8× 495 0.6× 278 0.7× 330 0.9× 476 1.7× 25 1.2k
Daniel Wai United States 22 616 0.7× 945 1.1× 362 0.9× 514 1.4× 96 0.3× 42 1.7k
Anna Caliò Italy 22 830 1.0× 560 0.7× 296 0.7× 599 1.6× 239 0.8× 74 1.4k
Gaëlle Pérot France 27 1.2k 1.4× 602 0.7× 366 0.9× 776 2.1× 192 0.7× 46 2.2k
Sophie Giraud France 28 984 1.1× 889 1.0× 458 1.1× 446 1.2× 328 1.1× 71 2.4k
Jau‐Yu Liau Taiwan 25 414 0.5× 488 0.6× 256 0.6× 841 2.2× 422 1.5× 79 1.7k
Man Yee Lui United States 9 1.6k 1.8× 1.0k 1.2× 451 1.1× 505 1.3× 188 0.7× 10 2.0k
Sabrina Croce France 24 616 0.7× 405 0.5× 310 0.8× 378 1.0× 281 1.0× 97 1.9k
Raluca Yonescu United States 20 420 0.5× 556 0.6× 349 0.9× 724 1.9× 671 2.3× 39 1.6k

Countries citing papers authored by Qiu Rao

Since Specialization
Citations

This map shows the geographic impact of Qiu Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiu Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiu Rao more than expected).

Fields of papers citing papers by Qiu Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiu Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiu Rao. The network helps show where Qiu Rao may publish in the future.

Co-authorship network of co-authors of Qiu Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Qiu Rao. A scholar is included among the top collaborators of Qiu Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiu Rao. Qiu Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Qiu, et al.. (2025). PIDGN: An explainable multimodal deep learning framework for early prediction of Parkinson's disease. Journal of Neuroscience Methods. 415. 110363–110363. 4 indexed citations
2.
Pan, Rui, Xiaotong Wang, Ru Fang, et al.. (2025). GPNMB expression differentiates subependymal giant cell astrocytoma from other mimickers. Annals of Diagnostic Pathology. 75. 152442–152442. 1 indexed citations
4.
Yang, Zhen, Mei Song, Xinbo Huang, et al.. (2025). AdaptiveGS: an explainable genomic selection framework based on adaptive stacking ensemble machine learning. Theoretical and Applied Genetics. 138(9). 204–204. 1 indexed citations
5.
Rao, Qiu, Y. Chen, Binghong Gao, et al.. (2024). 759P JSKN003, a HER2-targeting antibody-drug conjugate, in patients with platinum-resistant ovarian cancer: A pooled analysis of two studies. Annals of Oncology. 35. S575–S576. 3 indexed citations
6.
Wang, Xiaotong, Qiuyuan Xia, Ru Fang, et al.. (2022). Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity. Human Pathology. 123. 102–112. 7 indexed citations
9.
Xia, Qiuyuan, Qiu Rao, Yang Shao, et al.. (2021). Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases. Diagnostic Pathology. 16(1). 114–114. 9 indexed citations
10.
Fang, Ru, Qiuyuan Xia, Jing Sun, et al.. (2019). Hypermethylation of BRM promoter plays oncogenic roles in development of clear cell renal cell carcinoma. Journal of Cancer. 10(21). 5256–5263. 4 indexed citations
11.
Lv, Jinghuan, Donglin Zhu, Xiaotong Wang, et al.. (2018). The Value of Prognostic Factors for Survival in Synchronous Multifocal Lung Cancer: A Retrospective Analysis of 164 Patients. The Annals of Thoracic Surgery. 105(3). 930–936. 18 indexed citations
12.
Ni, Hao, Xiaotong Wang, Ru Fang, Xiaojun Zhou, & Qiu Rao. (2017). Gene Fusions in Human Cancers: A Review Focused on Diagnostic Biomarkers, Method Selections, and Treatments. Critical Reviews™ in Oncogenesis. 22(5-6). 403–410. 3 indexed citations
13.
Xia, Qiuyuan, Xiaotong Wang, Hao Chen, et al.. (2017). Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC. The American Journal of Surgical Pathology. 41(5). 663–676. 42 indexed citations
14.
Ni, Hao, Xueping Zhang, Xiaotong Wang, et al.. (2016). Extended immunologic and genetic lineage of mammary analogue secretory carcinoma of salivary glands. Human Pathology. 58. 97–104. 12 indexed citations
16.
Shen, Qin, Bo Yu, Shanshan Shi, et al.. (2015). Comparing four different ALK antibodies with manual immunohistochemistry (IHC) to screen for ALK -rearranged non-small cell lung cancer (NSCLC). Lung Cancer. 90(3). 492–498. 24 indexed citations
17.
Shen, Qin, Qiu Rao, Qiuyuan Xia, et al.. (2014). Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: Clinicopathological, immunohistochemical, and molecular features. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(5). 607–613. 44 indexed citations
18.
Rao, Qiu, Sean R. Williamson, Antonio López-Beltrán, et al.. (2013). Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Modern Pathology. 26(5). 725–732. 62 indexed citations
19.
Rao, Qiu, Biao Liu, Liang Cheng, et al.. (2012). Renal Cell Carcinomas With t(6;11)(p21;q12). The American Journal of Surgical Pathology. 36(9). 1327–1338. 60 indexed citations
20.
Pan, Min, et al.. (2008). Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Digestive and Liver Disease. 40(7). 560–567. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026